BPC-157

Investigational Peptide for Tissue Recovery and Gastrointestinal Wellness

What should you know?

BPC-157 is an investigational peptide that has been studied for its possible role in tissue recovery, gastrointestinal wellness, and regenerative pathways. It is also being investigated for its potential to support muscles, tendons, ligaments, joints, and the gastrointestinal lining. Its safety and effectiveness continue to be evaluated, and any use requires an individual medical assessment.

Possible side effects

  • Injection site irritation or redness
  • Headache
  • Dizziness
  • Nausea
  • Fatigue
  • Other mild symptoms

Do not use if pregnant, breastfeeding, or trying to become pregnant. Patients with significant medical conditions should consult our medical team before treatment.

Key information

  • Investigational peptide being studied for its possible role in tissue recovery andregenerative pathways.
  • Under investigation for its potential to support muscles, tendons, ligaments, andjoints.
  • Also being studied for its potential role in gastrointestinal lining wellness.
  • Requires medical evaluation and ongoing follow-up.

Important

BPC-157 is an investigational peptide and is not approved by the U.S. Food and Drug Administration (FDA). Its safety and effectiveness continue to be evaluated.

BPC-157 is prohibited by the World Anti-Doping Agency (WADA) for athletes subject to its regulations.

Before treatment, our physicians will review the potential risks, benefits, limitations, and available alternatives.

Restrictions apply. Adults 18 years of age or older only.